Wis. Admin. Code Controlled Substances Board CSB 2.65

Current through December 30, 2024
Section CSB 2.65 - Addition of approved cannabidiol drugs to schedule V

Section 961.22(7), Stats., is created to read:

961.22 (7) Approved cannabidiol drugs. A drug product in finished dosage formulation that has been approved by the United States food and drug administration that contains cannabidiol (2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) derived from cannabis and no more than 0.1 percent (w/w) residual tetrahydrocannabinols.

Wis. Admin. Code Controlled Substances Board CSB 2.65

Adopted by, cr. Affirmative action order under s. 961.11(4g), Stats., Register October 2018 No. 754, eff. 10/15/2018
Amended by, CR 19-012: cr. Register June 2020 No. 774, eff. 7/1/2020